These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 28978267)

  • 1. Review of Vascular Graft Studies in Large Animal Models.
    Liu RH; Ong CS; Fukunishi T; Ong K; Hibino N
    Tissue Eng Part B Rev; 2018 Apr; 24(2):133-143. PubMed ID: 28978267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The challenge of small diameter vascular grafts.
    Burkel WE
    Med Prog Technol; 1988-1989; 14(3-4):165-75. PubMed ID: 2978590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Creation of viable pulmonary artery autografts through tissue engineering.
    Shinoka T; Shum-Tim D; Ma PX; Tanel RE; Isogai N; Langer R; Vacanti JP; Mayer JE
    J Thorac Cardiovasc Surg; 1998 Mar; 115(3):536-45; discussion 545-6. PubMed ID: 9535439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patency and in vivo compatibility of bacterial nanocellulose grafts as small-diameter vascular substitute.
    Weber C; Reinhardt S; Eghbalzadeh K; Wacker M; Guschlbauer M; Maul A; Sterner-Kock A; Wahlers T; Wippermann J; Scherner M
    J Vasc Surg; 2018 Dec; 68(6S):177S-187S.e1. PubMed ID: 29248244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomaterials for vascular tissue engineering.
    Ravi S; Chaikof EL
    Regen Med; 2010 Jan; 5(1):107-20. PubMed ID: 20017698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic and semibiologic vascular grafts.
    Hansen OK; Kraft O; Mouritzen C
    Surg Gynecol Obstet; 1974 Jun; 138(6):940-4. PubMed ID: 4275051
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biomaterials and technologies for vascular grafts: from bench to bedside].
    Losi P; Briganti E; Vaghetti M; Soldani G
    Recenti Prog Med; 2013 Jan; 104(1):1-9. PubMed ID: 23439534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vascular grafts. I. Experimental study of autografts].
    JACOBELLIS P; TADDEINI L
    Rend Ist Sup Sanit; 1955; 18(5):406-18. PubMed ID: 13255110
    [No Abstract]   [Full Text] [Related]  

  • 9. Construction of an autologous tissue-engineered venous conduit from bone marrow-derived vascular cells: optimization of cell harvest and seeding techniques.
    Roh JD; Brennan MP; Lopez-Soler RI; Fong PM; Goyal A; Dardik A; Breuer CK
    J Pediatr Surg; 2007 Jan; 42(1):198-202. PubMed ID: 17208565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue-engineered small-caliber vascular graft based on a novel biodegradable composite fibrin-polylactide scaffold.
    Tschoeke B; Flanagan TC; Koch S; Harwoko MS; Deichmann T; Ellå V; Sachweh JS; Kellomåki M; Gries T; Schmitz-Rode T; Jockenhoevel S
    Tissue Eng Part A; 2009 Aug; 15(8):1909-18. PubMed ID: 19125650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citric acid-based elastomers provide a biocompatible interface for vascular grafts.
    Kibbe MR; Martinez J; Popowich DA; Kapadia MR; Ahanchi SS; Aalami OO; Jiang Q; Webb AR; Yang J; Carroll T; Ameer GA
    J Biomed Mater Res A; 2010 Apr; 93(1):314-24. PubMed ID: 19569210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-engineered blood vessels: alternative to autologous grafts?
    Hoenig MR; Campbell GR; Rolfe BE; Campbell JH
    Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1128-34. PubMed ID: 15705929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective randomized study of heparin-bonded graft (Propaten) versus standard graft in prosthetic arteriovenous access.
    Shemesh D; Goldin I; Hijazi J; Zaghal I; Berelowitz D; Verstandig A; Olsha O
    J Vasc Surg; 2015 Jul; 62(1):115-22. PubMed ID: 25770987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-bonded expanded polytetrafluoroethylene femoropopliteal bypass grafts outperform expanded polytetrafluoroethylene grafts without heparin in a long-term comparison.
    Samson RH; Morales R; Showalter DP; Lepore MR; Nair DG
    J Vasc Surg; 2016 Sep; 64(3):638-47. PubMed ID: 27139782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular Matrix for Small-Diameter Vascular Grafts.
    Kimicata M; Swamykumar P; Fisher JP
    Tissue Eng Part A; 2020 Dec; 26(23-24):1388-1401. PubMed ID: 33231135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue engineering of small diameter vascular grafts.
    Teebken OE; Haverich A
    Eur J Vasc Endovasc Surg; 2002 Jun; 23(6):475-85. PubMed ID: 12093061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells.
    Shin'oka T; Matsumura G; Hibino N; Naito Y; Watanabe M; Konuma T; Sakamoto T; Nagatsu M; Kurosawa H
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1330-8. PubMed ID: 15942574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Readily available tissue-engineered vascular grafts.
    Dahl SL; Kypson AP; Lawson JH; Blum JL; Strader JT; Li Y; Manson RJ; Tente WE; DiBernardo L; Hensley MT; Carter R; Williams TP; Prichard HL; Dey MS; Begelman KG; Niklason LE
    Sci Transl Med; 2011 Feb; 3(68):68ra9. PubMed ID: 21289273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts.
    Laredo J; Xue L; Husak VA; Ellinger J; Singh G; Zamora PO; Greisler HP
    J Vasc Surg; 2004 May; 39(5):1059-65. PubMed ID: 15111862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering blood vessels by gene and cell therapy.
    Zarbiv G; Preis M; Ben-Yosef Y; Flugelman MY
    Expert Opin Biol Ther; 2007 Aug; 7(8):1183-91. PubMed ID: 17696817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.